These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 8082411)
1. In vitro sensitivity of medically significant Fusarium species to various antimycotics. Sekhon AS; Padhye AA; Garg AK; Ahmad H; Moledina N Chemotherapy; 1994; 40(4):239-44. PubMed ID: 8082411 [TBL] [Abstract][Full Text] [Related]
3. Susceptibility of clinical isolates of Fusarium to antifungal drugs. Speeleveld E; Gordts B; Van Landuyt HW; De Vroey C; Raes-Wuytack C Mycoses; 1996; 39(1-2):37-40. PubMed ID: 8786755 [TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole. Martín E; Parras P; Lozano MC Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508 [TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole. Sekhon AS; Garg AK; Padhye AA; Hamir Z Eur J Epidemiol; 1993 Sep; 9(5):553-8. PubMed ID: 8307142 [TBL] [Abstract][Full Text] [Related]
6. [Molecular identification and in vitro susceptibility of Fusarium from fungal keratitis in central China]. Sun S; Lyu Q; Han L; Ma Q; Hu H; He S; Tao S; Zhang J; Zhang H; Wang L Zhonghua Yan Ke Za Zhi; 2015 Sep; 51(9):660-7. PubMed ID: 26693650 [TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method. Reuben A; Anaissie E; Nelson PE; Hashem R; Legrand C; Ho DH; Bodey GP Antimicrob Agents Chemother; 1989 Sep; 33(9):1647-9. PubMed ID: 2817867 [TBL] [Abstract][Full Text] [Related]
8. In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents. Sekhon AS; Padhye AA; Garg AK Eur J Epidemiol; 1992 May; 8(3):427-32. PubMed ID: 1397206 [TBL] [Abstract][Full Text] [Related]
9. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp. Lewis RE; Wiederhold NP; Klepser ME Antimicrob Agents Chemother; 2005 Mar; 49(3):945-51. PubMed ID: 15728887 [TBL] [Abstract][Full Text] [Related]
10. Fusarium keratitis in South India: causative agents, their antifungal susceptibilities and a rapid identification method for the Fusarium solani species complex. Homa M; Shobana CS; Singh YR; Manikandan P; Selvam KP; Kredics L; Narendran V; Vágvölgyi C; Galgóczy L Mycoses; 2013 Sep; 56(5):501-11. PubMed ID: 23437826 [TBL] [Abstract][Full Text] [Related]
11. [Detection of virulence factors and antifungal susceptibilities of Fusarium strains isolated from keratitis cases]. Çuhadar T; Karabıçak N; Özdil T; Özgür D; Otağ F; Hızel K; Kalkancı A Mikrobiyol Bul; 2018 Jul; 52(3):247-258. PubMed ID: 30156511 [TBL] [Abstract][Full Text] [Related]
12. International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method. Espinel-Ingroff A; Colombo AL; Cordoba S; Dufresne PJ; Fuller J; Ghannoum M; Gonzalez GM; Guarro J; Kidd SE; Meis JF; Melhem TM; Pelaez T; Pfaller MA; Szeszs MW; Takahaschi JP; Tortorano AM; Wiederhold NP; Turnidge J Antimicrob Agents Chemother; 2016 Feb; 60(2):1079-84. PubMed ID: 26643334 [TBL] [Abstract][Full Text] [Related]
13. Synergysm of voriconazole or itraconazole with other antifungal agents against species of Fusarium. Spader TB; Venturini TP; Rossato L; Denardi LB; Cavalheiro PB; Botton SA; Santurio JM; Alves SH Rev Iberoam Micol; 2013; 30(3):200-4. PubMed ID: 23402831 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of amphotericin B, hamycin and their novel water-soluble compounds against pathogenic yeasts. Sekhon AS; Padhye AA; Garg AK; Hamir Z Chemotherapy; 1992; 38(5):297-302. PubMed ID: 1286573 [TBL] [Abstract][Full Text] [Related]
15. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia. Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082 [TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients. Li L; Wang Z; Li R; Luo S; Sun X Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669 [TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of Mucor ramosissimus Samutsevitsch, a rare fungal pathogen, to antimycotics. Sharma R; Sekhon AS; Premachandra BR Chemotherapy; 1995; 41(3):200-3. PubMed ID: 7656666 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of antimicrobial agents against Fusarium species. Kawakami H; Inuzuka H; Hori N; Takahashi N; Ishida K; Mochizuki K; Ohkusu K; Muraosa Y; Watanabe A; Kamei K Med Mycol; 2015 Aug; 53(6):603-11. PubMed ID: 25841054 [TBL] [Abstract][Full Text] [Related]
19. [In vitro comparative study of the sensitivity of Aspergillus to antifungal agents]. Guinet R; Mazoyer MA Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):654-7. PubMed ID: 6462761 [TBL] [Abstract][Full Text] [Related]
20. Molecular and MALDI-ToF MS differentiation and antifungal susceptibility of prevalent clinical Fusarium species in China. Song Y; Liu X; Yang Z; Meng X; Xue R; Yu J; Al-Hatmi AMS; de Hoog GS; Li R Mycoses; 2021 Oct; 64(10):1261-1271. PubMed ID: 34173979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]